In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
LM_ID | Common Name | Systematic Name | Formula | Mass |
---|---|---|---|---|
LMFA04010304 | 10,13-diepi-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010305 | 10,13-diepi-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010306 | 10-epi-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010307 | ent-10-epi-10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010308 | ent-10,13-diepi-10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010309 | ent-10,13-diepi10-10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010310 | ent-10-epi-10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010311 | 10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010312 | 13-epi-10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010313 | 13-epi-10-E4c-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010314 | 10-E4t-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010315 | ent-11-E4t-NeuroP | 3-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010316 | ent-4-epi-11-E4c-NeuroP | 3-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010317 | ent-4-epi-11-E4t-NeuroP | 3-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010318 | ent-11-E4c-NeuroP | 3-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010319 | 11-epi-11-E4c-NeuroP | 3-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010320 | 4,11-diepi-11-E4t-NeuroP | 3-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010321 | 4,11-diepi-11-E4c-NeuroP | 3-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010322 | 11-epi-11-E4t-NeuroP | 3-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010323 | ent-11-epi-11-E4t-NeuroP | 3-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010324 | ent-4,11-diepi-11-E4c-NeuroP | 3-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010325 | ent-4,11-diepi-11-E4t-NeuroP | 3-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010326 | ent-11-epi-11-E4c-NeuroP | 3-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010327 | 11-E4c-NeuroP | 3-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010328 | 4-epi-11-E4t-NeuroP | 3-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010329 | 4-epi-11-E4c-NeuroP | 3-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010330 | 11-E4t-NeuroP | 3-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid | C22H32O5 | 376.2250 |
LMFA04010331 | ent-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010332 | ent-16-epi-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010333 | ent-16-epi-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010334 | ent-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010335 | 13-epi-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010336 | 13,16-diepi-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010337 | 13,16-diepi-13-E4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010338 | 13-epi-13-E4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010339 | ent-13-epi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010340 | ent-13,16-diepi-13-E4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010341 | ent-13,16-diepi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010342 | ent-13-epi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010343 | 13-E4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010344 | 16-epi-13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010345 | 16-epi-13-E4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010346 | 13-E4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H32O5 | 376.2250 |
LMFA04010347 | ent-14-E4t-NeuroP | (Z)-6-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010348 | ent-7-epi-14-E4c-NeuroP | (Z)-6-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010349 | ent-7-epi-14-E4t-NeuroP | (Z)-6-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010350 | ent-14-E4c-NeuroP | (Z)-6-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010351 | ent-14-epi-14-E4t-NeuroP | (Z)-6-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010352 | ent-7,14-diepi-14-E4c-NeuroP | (Z)-6-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010353 | ent-7,14-diepi-14-E4t-NeuroP | (Z)-6-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |